Thus, future studies should evaluate the beneficial effects of targeting MPO and ANGPTL6 simultaneously for the treatment of both obesity and T2D by inhibiting the activity of MPO and overexpression of ANGPTL6. This evidence concerns the gene ANGPTL6 and Obesity.